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Background:  This study was done to evaluate the effect on pain relief when acetaminophen was added to lidocaine 
for intravenous regional anesthesia (IVRA). 
Methods:  Sixty patients undergoing hand or forearm surgery received IVRA were assigned to three groups: Group 
C received 0.5% lidocaine diluted with 0.9% normal saline to a total volume of 40 ml (n = 20), Group P received 0.5% 
lidocaine diluted with intravenous acetaminophen 300 mg to a total volume of 40 ml (n = 20) and Group K received 
0.5% lidocaine diluted with 0.9% normal saline plus ketorolac 10 mg made up to a total volume of 40 ml (n = 20).   
Sensory block onset time, tourniquet pain onset time, which was defined as the time from tourniquet application 
to fentanyl administration for relieving tourniquet pain and amount of analgesic consumption during surgery were 
recorded.  Following deflation of tourniquet sensory recovery time, postoperative pain and quantity of analgesic uses 
in post-anesthesia care unit were assessed. 
Results:  Sensory block onset time was shorter in Group P compared to Group C (P < 0.05).  Tourniquet pain 
onset time was delayed in Group P when compared with group C (P < 0.05).  Postoperative pain and analgesic 
consumption were reduced in Group P and Group K compared to Group C (P < 0.001). 
Conclusions:  The addition of acetaminophen to lidocaine for IVRA shortens the onset time of sensory block and 
delays tourniquet pain onset time, but not with ketorolac.  Both acetaminophen and ketorolac reduce postoperative 
pain and analgesic consumption.  (Korean J Anesthesiol 2010; 58: 357-361)
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Introduction 
    Intravenous regional anesthesia (IVRA) was first used by 
August Bier in 1908 [1]. This technique is easy, reliable and cost-
effective when used in short operative procedures of hand or 
forearm [2]. Tourniquet pain and lack of postoperative analgesia 
after tourniquet release are the major limitations to this 
technique. To improve the efficacy of IVRA, various agents such 
as tramadol [3], clonidine [4], neostigmine [5] are added to the 
local anesthetics. Also various nonsteroidal anti-inflammatory 
drugs (NSAIDs) have been demonstrated to enhance analgesia 
such as ketorolac, in IVRA [6,7]. 
    Acetaminophen is an analgesic which relieves pain and reduces 
fever. Perfalgan
TM (Bristol-Myers Squibb, France) is a solution of 
acetaminophen administrated intravenously in order to relieve 
pain or reduce fever following surgery. 
    We planned this study to evaluate the effect of intravenous 
acetaminophen and ketorolac on sensory block onset times, 
tourniquet pain and postoperative analgesia when added to 
lidocaine for IVRA.
Materials and Methods 
    Sixty patients with American Society of Anesthegiologists 
(ASA) physical status I or II, aged between 17 and 60 years, who 
were scheduled for surgery of the hand or the forearm were 
included in this study after informed consent. Patients with 
sickle cell anemia, Raynaud’s disease, history of drug allergy, 
liver disease, kidney disease were excluded from the study. 
    This prospective, double-blinded, randomized, interventions 
study, conducted in the patients undergoing hand or forearm 
surgery were randomly assigned in three groups: Group C- 
patients received 0.5% lidocaine diluted with 0.9% normal saline 
to a total volume of 40 ml (n = 20), Group P- patients received 
0.5% lidocaine diluted with intravenous acetaminophen 300 
mg (Perfalgan 30 ml) to a total volume of 40 ml (n = 20) and 
Group K- patients received 0.5% lidocaine diluted with 0.9% 
normal saline plus ketorolac 10 mg to a total volume of 40 ml 
(n = 20). There was no significant difference among groups for 
age, height, weight, duration of operation time, tourniquet time 
and sex ratio (Table 1). The types of operations performed are 
presented in Table 2. There were no exclusions from the study 
due to technical failure.
    After the patients had been taken to the operating room, mean 
arterial blood pressure (MAP), peripheral oxygen saturation 
(SpO2), and heart rate (HR) were monitored. Before establishing 
the anesthetic block, two cannulae were placed; one in dorsal 
vein of the operative hand for anesthetic drug administration 
and the other in opposite hand for crystalloid infusion. The 
operative arm was exsanguinated with an Esmarch bandage, 
and a pneumatic tourniquet was placed around the upper arm. 
The proximal cuff was inflated to 250 mmHg and maintained in 
the same position. Circulatory isolation of arm was verified by 
inspection, absence of radial pulse, and loss of pulse oximetry 
tracing of the ipsilateral index finger. After the bandage was 
removed, 40 ml of the respective solutions were injected for the 
period of 60 seconds.
    The sensory block was assessed by a pinprick test using a 22- 
gauge short-beveled needle taken out continuously every 30 
seconds. Patient response was evaluated in the dermatomal 
sensory distribution of the medial and lateral antebrachial 
cutaneous, ulnar, median, and radial nerves. After sensory 
block was achieved, the distal cuff was inflated to 250 mmHg 
followed by release of the proximal tourniquet and operation 
was then started.
    Assessment of tourniquet pain using the visual analog scale 
Table 1.  Demographic Data, Total Operation Time and Total Tourni-
quet Application Time
Group C 
(n = 20)
Group P 
(n = 20)
Group K 
(n = 20)
Age (yr)
Gender (M/F)
Weight (kg)
Height (cm)
Duration of operation (min)
Tourniquet application time (min)
  40.0 ± 12.5
11/9
  65.2 ± 5.9
165.5 ± 8.0
  36.8 ± 16.9
  50.2 ± 14.5
  42.7 ± 13.9
10/10
  64.6 ± 13.6
165.3 ± 10.7
  34.0 ± 22.1
  47.3 ± 13.3
  40.3 ± 16.2
11/9
  64.7 ± 10.8
166.6 ± 10.0
  29.0 ± 15.1
  47.6 ± 13.3
Values are number of patients or mean ± SD. Group Creceived 0.5% 
lidocaine diluted with 0.9% normal saline to a total volume of 40 ml 
for IVRA. Group P received 0.5% lidocaine diluted with intravenous 
acetaminophen 300 mg to a total volume of 40 ml. Group K re-
ceived0.5% lidocaine diluted with 0.9% normal saline plus ketololac 
10 mg to a total volume of 40 ml. There are no significant difference 
among the groups.
Table 2.  Typesof Operations Performed
The types of operation 
Group C 
(n = 20)
Group P 
(n = 20)
Group K 
(n = 20)
Ganglion excision
Finger fracture close reduction
Carpal tunnel syndrome
Radius fracture close reduction
Hardware removal of forearm
Hand laceration
Mallet finger
Trigger thumb
3
3
5
3
2
3
1
0
4
2
3
1
5
1
1
3
4
0
5
1
3
3
3
1
Values are number of patients. Group Creceived 0.5% lidocaine 
diluted with 0.9% normal saline to a total volume of 40 ml for IVRA. 
Group P received 0.5% lidocaine diluted with intravenous aceta-
minophen 300 mg to a total volume of 40 ml. Group K received 0.5% 
lidocaine diluted with 0.9% normal saline plus ketololac 10 mg to a 
total volume of 40 ml.359 www.ekja.org
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(VAS) (0 = no pain and 10 = worst pain imaginable) were moni-
tored at 5, 10, 20, 30 and 40 min after tourniquet application. 
Intermittent bolus of 1 μg/kg fentanyl were administrated for 
tourniquet pain treatment when VAS > 3. The onset time of 
tourniquet pain time was recorded (the time elapsed after 
tourniquet inflation to first patient reported VAS > 3). The total 
fentanyl consumption for maintaining VAS below 3 was also 
recorded. During operation if there was no tourniquet pain 
more than VAS 3, tourniquet pain onset time was accepted as 
the duration of tourniquet application time. 
    The tourniquet was not deflated within 40 min and was 
not inflated more than 1.5 hours. At the end of surgery, the 
tourniquet deflation was performed by the cyclic deflation 
technique (the tourniquet was deflated three times in a cyclic 
manner with 10 second periods of deflation separated by 1 
minute periods of reinflation). Sensory recovery time was noted 
(time elapsed after tourniquet deflation up to recovery of pain 
in all dermatomes determined by pinprick test). 
    Assessment of postoperative surgical pain scores using VAS 
were checked every 30 min after tourniquet deflation for 2 
hours in postanesthesia care unit and highest VAS of each 
patient was noted as postoperative VAS score. In postanesthesia 
care unit, patient received tramadol 50 mg when VAS was > 3, 
and total amounts of tramadol administered to each group were 
recorded. 
    During the intraoperative period and postoperative period, 
any local or systemic complications were recorded for 24 hours 
in the ward.
    Statistical analysis was performed with Medcalc
TM for 
windows version 9.1 (Frank schoonjans, Belgium). Comparison 
among the groups was made with one-way analysis of variance 
(ANOVA). Significance was assumed at P < 0.05.
Results
    Sensory block onset time was significantly shorter in Group P 
than in group C (P < 0.05). There was no significant difference 
among groups when compared for sensory block recovery time 
(Table 3). 
    There was no significance among groups for intraoperative 
total amount of fentanyl consumption (P = 0.093). The number 
of patients who required fentanyl were eleven in Group C, eight 
in Group P, thirteen in Group C. Tourniquet pain onset time 
was significantly longer in Group P than other groups (P < 0.05) 
(Table 3).
    There was no significant difference among groups when 
compared against VAS scores for tourniquet pain (Table 4).
    Postoperative VAS score in Group P and Group K were signifi-
cantly lower than Group C (P < 0.001) (Table 4). Twelve patients 
of Group C were given additional analgesic (tramadol 50 mg) 
in postanesthesia care unit, whereas four patients of Group 
P and only one patient of Group K were given tramadol. The 
postoperative analgesic consumption was significantly lower in 
Group P and Group K than group C (P < 0.001) (Table 4).
    No patient developed hypotension, hypoxemia, bradycardia 
or any other adverse events in intraoperative and postoperative 
period over a period of 24 hours in ward.
Discussion
    The primary outcome of this study was - addition of intravenous 
acetaminophen to lidocaine for IVRA decreased onset time 
of sensory block, postoperative pain, postoperative analgesic 
Table 3.  Onset and Recovery Time of Sensory Block, Tourniquet Pain 
Onset Time, Intraoperative Fentanyl Consumption and Number of 
Patients who Required Fentanyl
Group C 
(n = 20)
Group P 
(n = 20)
Group K 
(n = 20)
Sensory block
    Onset time (min)
    Recovery time (min)
Tourniquet pain onset time (min)
Intraoperative fentanyl 
  consumption (μg)
Patients who required fentanyl (n)
3.6 ± 1.6
3.0 ± 2.0
26.4 ± 10.7
35.3 ± 33.1
11
2.3 ± 1.4*
2.6 ± 1.0
34.6 ± 7.8*
 22 ± 28.7
8
3.1 ± 1.4
3.2 ± 1.8
28.6 ± 10.8
    42 ± 33.2
13
Values are number of patients or mean ± SD. Group Creceived 0.5% 
lidocaine diluted with 0.9% normal saline to a total volume of 40 ml 
for IVRA. Group P received 0.5% lidocaine diluted with intravenous 
acetaminophen 300 mg to a total volume of 40 ml. Group K received 
0.5% lidocaine diluted with 0.9% normal saline plus ketololac 10 mg 
to a total volume of 40 ml. *P < 0.05 compared with Group C. 
Table 4. VAS Scores after Tourniquet Inflation, Postoperative VAS 
Scores, Tramadol Consumption and Number of Patients who Re-
quired Tramadol
Group C 
(n = 20)
Group P 
(n = 20)
Group K 
(n = 20)
VAS scores after tourniquet inflation 
    5 min
    10 min
    20 min
    30 min
    40 min
Postoperative VAS scores
Postoperative tramadol 
  consumption (mg)
Patients who required tramadol (n)
1.4 ± 1.3
1.8 ± 1.6
2.7 ± 2.1
3.1 ± 4.4
4.3 ± 2.5
3.8 ± 2.4
30.0 ± 25.1
12
  
  0.9 ± 1.2
  1.2 ± 1.3
  2.2 ± 1.6
  3.0 ± 1.8
  4.5 ± 2.3
  2.2 ± 1.6*
10.0 ± 20.5*
4*
1.3 ± 1.3
2.0 ± 1.6
3.4 ± 2.3
3.5 ± 1.8
4.2 ± 1.7
1.4 ± 1.2*
2.5 ± 11.2*
1*
Values are number of patients or mean ± SD. Group Creceived 0.5% 
lidocaine diluted with 0.9% normal saline to a total volume of 40 ml 
for IVRA. Group P received 0.5% lidocaine diluted with intravenous 
acetaminophen 300 mg to a total volume of 40 ml. Group K received 
0.5% lidocaine diluted with 0.9% normal saline plus ketololac 10 mg 
to a total volume of 40 ml. *P < 0.05 compared with Group C.  360 www.ekja.org
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consumption and delayed tourniquet pain onset time.
    In the pilot study that was conducted we discovered that some 
of the cases faced a delay in surgery as the motor block was not 
achieved even after IVRA. Therefore, we did not asses onset and 
recovery time of motor block in this study. Further studies are 
therefore required to know the effects on motor block. 
    It is known that by increase in pH of local anesthetics improves 
the nerve penetration and rate of onset of blockade [2], we 
investigate pH of each solution used in this study. The pH of 
lidocaine-normal saline solution was 6.16 (Group C), and that 
of lidocaine-normal saline-ketorolac mixture was 6.28 (Group 
K) and the pH value of lidocaine-intravenous acetaminophen 
mixture was 5.88 (Group P). Although the pH of lidocaine-
intravenous acetaminophen mixture was lower than other 
groups, onset time of sensory block was much faster in Group 
P compared to Group C. This effect may be as a result of 
acetaminophen's antinociceptive effect at pheripheral site.
    NSAIDs are widely used concomitantly with IVRA to improve 
the quality of anesthesia. It is known that the analgesic effect 
of NSAID is attributed to inhibition of the isoenzyme COX-2 
[8] that is primarily associated with inflammation. Cytokines 
and growth factors enhance the expression and synthesis of 
COX-2, mainly at inflammatory sites, producing prostaglandins 
that mediate inflammation, pain and fever [9]. Reuben et al. 
demonstrated that ketoroloac added to lidocaine improved 
control of tourniquet pain and postoperative pain [6]. The study 
also suggested that reduction of postoperative pain is as a result 
of residual ketorolac in the operative arm, and its redistribution 
to the systemic circulation after tourniquet deflation [7]. 
Studies have indicated that optimal dose of ketorolac for IVRA 
was 20 mg [7], but we used 10 mg of ketorolac, as 30 mg of 
ketorolac was shown to be equipotent with 1 g of intravenous 
acetaminophen [10]. In this study, postoperative pain and 
postoperative analgesic consumption were decreased in Group 
K than Group C but was ineffective in decreasing tourniquet 
pain and onset time of sensory block. Ketorolac 10 mg when 
added to IVRA may be insufficient to reduce tourniquet pain 
but its anti-inflammatory effect and systemic circulation after 
tourniquet deflation may reduce postoperative pain.
    The main mechanism of analgesic effect of acetaminophen 
is demonstrated to be through its action on central nervous 
system mediated by inhibition of prostaglandin synthesis 
[11,12]. Acetaminophen is also shown to inhibit cyclooxygenase 
(COX) enzyme in vivo [13,14]. 
    In a recent study, paracetamol added to lidocaine for IVRA 
improved quality of anesthesia and delayed tourniquet pain 
onset time, reduced intraoperative and postoperative analgesic 
consumption [15] in which paracetamol 300 mg was added 
to 40 ml solution for IVRA similar to present study. Sen H 
et al. [15] compared the IVRA lidocaine and paracetamol 
mixture with IVRA lidocaine plus intravenous acetaminophen 
whereas the present study compared the effects of IVRA 
lidocaine and acetaminophen mixture vs IVRA lidocaine and 
ketorolac mixture. The results of this study were comparable 
to the previous study, except that, in this study intravenous 
acetaminophen for IVRA did not significantly reduce intraope-
rative analgesic consumption. The time points of intraoperative 
analgesic administration were also different. Sen H et al. [15] 
used fentanyl for decreasing tourniquet pain when VAS > 4 but 
in the present study VAS > 3 was the cut-off pain score, thus 
intraoperative analgesics were administered in more number of 
patients than study conducted by Sen H et al. [15].
    Several studies have demonstrated the peripheral antinoci-
ceptive effect of acetaminophen. Lee et al. [16] have suggested 
that acetaminophen selectively suppressed peripheral prosta-
glandin E2 release and increased COX-2 gene expression in 
a clinical model of acute inflammation. In another study, 
acetaminophen may also interfere with the delivery of 
peripheral β-endorphins and help in reducing the pain [17]. 
Canbay et al. [18] have studied that 50 mg of intravenous aceta-
minophen pretreatment is effective in reducing the pain on 
propofol injection. Dani et al. [19] suggested that paracetamol 
exhibits local antinociceptive effects by modulating cannabi-
noid receptors.
    There were few limitations in this study. The dose of intra-
venous acetaminophen 300 mg was fixed for the reason that 
when intravenous acetaminophen over 300 mg was mixed 
then the total volume of IVRA solution would be too large and 
would be difficult to control the concentration of lidocaine. We 
anticipate that larger doses of acetaminophen would increase 
the efficacy of analgesic during IVRA but optimal dose of 
acetaminophen could not be determined. Another limitation is 
that motor block and delayed postoperative pain after patient 
discharge from postanesthesia care unit were not assessed. 
The variability in intraoperative pain or postoperative pain 
depending on the type of surgery performed such as carpal 
tunnel syndrome, close reduction of radius fracture, ganglion 
excision etc, could not be standardized (Table 2).
    In conclusion, this study indicated that the addition of intra-
venous acetaminophen to lidocaine in IVRA significantly shortens 
the onset time of sensory block, but not intravenous ketorolac. 
The addition of both drugs may not affect intraoperative anal-
gesia and tourniquet pain. However, both drugs would improve 
postoperative analgesia in postanesthesia care unit.
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